About Tower Cancer
It was established in 1996 by a dedicated group of physicians, patients, and volunteers with a personal stake in cancer.
Inspired by the most promising science, we fund leading researchers, making us a launchpad for additional funding and scientific discoveries.
Where We Invest:
- Scientific Research Grants: Funding scientific research to uncover the mechanisms by which cancer develops and spreads, creating a path to effectively treating and preventing the disease and creating the life-saving treatments of tomorrow.
- Survivorship Support: We invest in life-changing support for people affected by cancer today through Magnolia House.
While our programs and funding are made locally, they are designed to maximize impact beyond the initial investment — so they not only benefit researchers, patients, and families today, they have the potential to lead to even greater impact tomorrow, transforming lives anywhere.
Our Mission:
Through local investments, we advance groundbreaking cancer research and profoundly support people affected by the disease to create outsized impact in Southern California and beyond.
Board of Directors Executive Officers
Nancy Rosenfelt
Chair
Jonathan Layne
Development Committee Chair
Larry Rosenstein
Vice-Chair
Donna Rosen*
Immediate Past Chair
David Spingarn
Treasurer
Christopher Clinton Conway
Chief Executive Officer
Jeanne Schnitzer Marks
Secretary
We’re powered by a passionate team,
dedicated to building a cancer-free future.
Our auxiliary funding groups play a supporting but vital role in the organization’s growth and vitality.
Latest News
Yale School of Nursing – Health-Related Quality of Life in Women With Metastatic Breast Cancer
TCRC Study Researcher(s): Yan Zhan, PhD (c), MBA, BSN, RN, Yale University School of Nursing Summary/Abstract: The...
RECONJOINT – Survey to Assess Patient Preferences for Breast Reconstruction
Approximately 40% of breast reconstruction patients experience dissatisfaction due to inaccurate expectations of post-surgical well-being, and aesthetic and physical outcomes of surgery that do not reflect personal treatment preferences…